Indian Pharmaceutical Supplier to Oman.
Oman runs a public-tertiary system anchored by the Royal Hospital and Sultan Qaboos University Hospital (SQUH) in Muscat, supported by Khoula, Al Nahdha, Ibn Sina and the Armed Forces Hospital, with a growing private sector led by Muscat Private Hospital, Badr Al Samaa, Starcare, Al Hayat International and Aster Al Raffah. The distributor layer (Muscat Pharmacy, Ebrahim Pharmacy, Oman Pharmaceutical Products Company) is unusually important here and sits between the importer of record and the hospital-pharmacy window. Products enter through Muscat International (MCT), Salalah (SLL), and the sea ports at Sohar and Salalah, under the Directorate-General of Pharmaceutical Affairs and Drug Control. Our Mumbai regulatory desk files directly with DGPA; our Dubai commercial desk handles day-to-day coordination with Omani distributors and the MoH tender calendar.
DGPA, the GHC route and Tawteen.
The Directorate-General of Pharmaceutical Affairs and Drug Control sits inside the Omani Ministry of Health and holds the single authority to register imported finished pharmaceuticals. Submissions are ICH CTD with an Oman-specific Module 1 covering the letter of authorisation from the manufacturer, the GCC price notification and the proposed Arabic and English artwork. DGPA frequently accepts GHC central-registration approvals as the basis for a local authorisation, which shortens the review clock when the GHC pack is current and complete.
Timelines land at 9 to 13 months for a WHO-GMP generic with a clean dossier, API DMF and stability covering one year accelerated plus three months real-time. Biologics, complex injectables and new chemical entities take longer, usually 15 to 20 months. Pack-size and artwork variations clear in three to six months. Controlled substances run under a parallel narcotic-control permit, issued quarterly against a declared quota, and the importer of record must hold a valid narcotic licence.
Tawteen is the piece that first-time suppliers to Oman often underestimate. Under Oman Vision 2040, local-content weighting in public healthcare procurement has risen: the Omani distributor partner needs to demonstrate Omanisation employment ratios, and tender scoring increasingly reflects local-value-add alongside price. Our Dubai desk works with distributors that are already Tawteen-aligned, so the commercial proposal you receive is tender-ready rather than requiring a retrofit.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six capabilities, mapped to Omani procurement reality.
DGPA dossier preparation and filing
ICH CTD dossiers with Oman-specific Module 1, GCC price notification pack, artwork submission and the GHC-to-DGPA bridge where a central registration is already in hand. Variations and renewals tracked on a shared calendar with the Omani importer of record.
MoH tender response
Technical and commercial pack for Omani Ministry of Health tenders: DGPA number, CoA, CoO, GMP, PSUR, stability, Arabic artwork, Tawteen-aligned commercial proposal and a price schedule benchmarked against the GCC reference set.
Distributor-channel supply
Contract supply through Muscat Pharmacy, Ebrahim Pharmacy and OPPC, plus selective second-tier distributors for Salalah and the interior. Batch-level traceability, CoA and CoO per dispatch, QP release letter where the distributor's pharmacovigilance function requires it.
GHC joint registration
Gulf Health Council central-registration dossiers that pull Oman into a single six-state submission cycle with KSA, UAE, Kuwait, Qatar and Bahrain. Particularly efficient where Oman is not the lead market but needs to track the others on a predictable schedule.
Arabic bilingual artwork
DGPA-compliant Arabic typesetting with native-speaker medical review, outer-carton bilingual layout, PIL translation and artwork proof secured with DGPA before any print run commits.
Paediatric and respiratory lines
Oman's consanguinity-linked paediatric caseload and high asthma prevalence give respiratory and paediatric formulations steady draw. We maintain ICH-stability-compliant paediatric suspensions, nebuliser solutions and inhaler devices configured to Omani hospital-pharmacy specifications.
Two air gateways, two sea gateways, one bonded corridor.
Air freight: BOM-MCT is a three-hour block flight, with Oman Air, SalamAir, IndiGo and Air India Express running daily services. BOM-SLL adds a direct Salalah option for Dhofar-governorate deliveries and Salalah Free Zone-based customers; frequency is lower and transit typically pivots through Muscat for consolidations under 500 kilograms. Door-to-door for ambient cargo clears in two to four working days; DGPA import clearance at MCT is handled through the Bayan customs system with our nominated freight agent resolving landing-side queries.
Sea freight: Nhava Sheva to Sohar Port and Salalah Port runs six to eight days direct, with weekly sailings from Maersk, CMA CGM, MSC and ONE. Sohar is the preferred gateway for Muscat-bound volume because of the short truck leg into the capital (roughly two and a half hours along the Batinah coast); Salalah suits southern and east-Africa-facing customers and is itself one of the largest transshipment hubs on the Indian Ocean. Less-than-container-load consolidation is available for orders under 10 CBM.
Cold-chain: Envirotainer RAP e2 and RKN e1 for 2-8 degrees active, va-Q-tec passive for 15-25 ambient, and continuous temperature logging on every consignment with invoice value above USD 15,000. Muscat's cool-dolly capacity is adequate but thinner than Dubai's, so we time sensitive cargo to pair with Oman Air and Emirates cargo windows, and use Jebel Ali as a 24-to-48-hour fallback positioning point for Muscat call-offs. Summer tarmac conditions mean night-arrival slots are preferred for 2-8 product.
Payment terms: TT 30% advance and 70% against scanned BL for first-time customers, or a sight LC through Bank Muscat, National Bank of Oman or HSBC Oman. Repeat customers move to open account at 30 to 90 days after five clean shipments, subject to credit-insurer cover. Institute Cargo Clauses A insurance, door-to-door.
What Omani hospitals actually request.
Cardiometabolic leads the public-tender volume. Omani adult diabetes prevalence sits around 15%, obesity is rising in the under-40 cohort, and the cardiovascular draw is consistent. Statins, SGLT2 inhibitors, DPP-4 inhibitors, ARBs and long-acting insulin analogues run through the Royal Hospital and SQUH catchments, plus the Armed Forces Hospital. Respiratory is the second pillar: asthma prevalence across the Gulf is elevated, and Oman's dust-exposure profile adds to the paediatric and adult respiratory draw, so salbutamol, budesonide-formoterol and montelukast lines carry steady tender volume.
Paediatric formulations deserve a specific note. Consanguineous-marriage prevalence in Oman is among the world's highest, and the downstream paediatric-genetics caseload includes recurrent haemoglobinopathies, metabolic disorders and seizure syndromes. SQUH's paediatric and genetics units draw consistently on antiepileptics, paediatric-dose anti-infectives and specialist formulations. Oncology and supportive-care injectables, broad-spectrum antibiotics, ophthalmology and dermatology round out the hospital-formulary roster.
Every line ships with DGPA-compliant bilingual labelling, GCC-price-compliant commercial schedules and CoA-per-batch documentation.
A Muscat distributor migrated its paediatric antibiotics and respiratory suspension portfolio to M Care over 11 months starting mid-2024. We consolidated nine SKUs across two manufacturing partners, rewrote three artwork packs to DGPA's 2023 bilingual specification, and stood up a Sohar-routed container programme that held landed cost 17% below the incumbent European-origin benchmark. Batch-release documentation was pre-approved by their QP before each dispatch, trimming hospital-pharmacy goods-inward queries from an average 2.4 per consignment to 0.3 across 14 shipments.
Why Indian pharma, why M Care, and what an Omani buyer actually receives.
Oman has a smaller pharmaceutical volume than its Gulf neighbours but a more layered commercial chain: an importer of record, a primary distributor, often a secondary distributor, and then the hospital-pharmacy or retail window. Indian manufacturing lines up well with this structure because the unit economics of India-origin generics absorb the additional distributor margin without breaking the tender price ceiling. WHO-GMP capacity covers roughly a fifth of global finished-dosage-form volume, API costs stay 30 to 50% below European-origin, and ICH-aligned stability and English CTD documentation move cleanly through DGPA review.
The commercial answer is different from the UAE or Kuwait. In Oman, your choice of distributor shapes everything from tender access to retail shelf coverage, and picking the wrong one costs 18 to 24 months of rebuild. M Care works with distributors we have vetted against Tawteen compliance, hospital-pharmacy relationships and pharmacovigilance capacity. When you come to us with an Omani brief, we advise first on channel fit, second on molecule and pricing; the dossier work flows from those two conversations rather than preceding them.
Three specifics make the working relationship different. First, a single named account manager who owns your file from RFQ through re-order and through the inevitable mid-year quota recalibration. Second, GHC readiness: where an Omani launch is part of a broader GCC plan, we structure the dossier to file through the Gulf Health Council and pull Oman in on a harmonised schedule with KSA, UAE and the others. Third, realistic timing. We say 9 to 13 months for a DGPA generic because that is what clean submissions actually run; we do not quote six months and then chase extensions.
A practical point for first-time Omani buyers: Oman is often a rational second-wave launch market after UAE and KSA, where the GHC dossier has already done most of the work. If you are planning a multi-market rollout, we would rather sequence Oman into that plan than file a stand-alone DGPA submission that duplicates effort.
Oman pharmaceutical import: common questions.
Which authority registers pharmaceutical products in Oman?
The Directorate-General of Pharmaceutical Affairs and Drug Control (DGPA and DC) inside the Oman Ministry of Health. DGPA issues the registration number that appears on every imported commercial pack and on each MoH tender submission. Dossiers follow ICH CTD with an Oman-specific Module 1.
How long does DGPA registration typically take?
Nine to thirteen months for a WHO-GMP-sourced generic with a clean dossier, API DMF and stability covering one year accelerated plus three months real-time. New chemical entities and biologics run 15 to 20 months. A current GHC central registration usually compresses the DGPA review window further.
What does Tawteen mean for my pharmaceutical import?
Tawteen is Oman's Omanisation and local-content framework, now applied to healthcare procurement under Vision 2040. Practically, it shifts weighting onto your Omani distributor partner: they need Omanisation employment ratios in place, and tender scoring will reward local-value-add alongside price. We work with distributors that are already compliant, so your commercial proposal does not need a retrofit.
Which Omani distributors does M Care work with?
Primary partners include Muscat Pharmacy and Stores, Ebrahim Pharmacy and Oman Pharmaceutical Products Company (OPPC), with selective second-tier coverage for Salalah and the Dakhiliyah and Dhofar interiors. The choice depends on your molecule, your target hospital network and whether you want retail-shelf depth or hospital-tender focus.
Is Arabic labelling mandatory for Oman?
Yes. Outer carton bilingual Arabic and English, Arabic patient information leaflet for retail and OTC lines, and DGPA artwork approval before any print run. We commission the Arabic typesetting, run native-speaker medical review and secure DGPA sign-off as part of the pre-shipment pack.
What cold-chain routes do you use into Oman?
BOM-MCT direct on Oman Air, SalamAir, IndiGo and Air India Express, with Envirotainer or va-Q-tec containers and continuous temperature logging. BOM-SLL for Salalah-bound volume. Jebel Ali positioning is used as a 24-to-48-hour fallback when MCT cool-dolly windows are tight. Insurance on Institute Cargo Clauses A, door-to-door.
How is payment typically structured with Omani buyers?
First-time: TT 30% advance, 70% against scanned Bill of Lading, or a sight LC through Bank Muscat, National Bank of Oman or HSBC Oman. Repeat customers, post five clean shipments, move to open account at 30 to 90 days depending on volume and credit-insurer line. Atradius and Euler Hermes cover on larger accounts.
Why buyers choose M Care for the India → Oman corridor.
Oman MoH DGPA&DC fluency
Dossiers built to the exact format Oman MoH DGPA&DC reviews, not a generic CTD dump. We know which modules get scrutinised first, which stability data triggers queries, and which legalisation and apostille chain the submission needs to clear on the first pass.
Logistics you can schedule around
BOM → MCT direct air for time-critical orders, and Sohar for high-volume ambient sea freight. Cold-chain SKUs run on validated containers with continuous temperature logging. Consolidation at origin so you order by molecule, not by MOQ.
Commercial discipline, one point of contact
USD invoicing with clear FX-clause language, LC / TT / open-account progression as the relationship proves out, 18 therapeutic areas on one PO, and one named account manager from enquiry through clearance in Oman.
Top categories we ship to Oman
Anti-infectives
Penicillins, cephalosporins, carbapenems, antivirals, antimalarials — 1,800+ hospital and retail lines.
Cardiovascular
Antihypertensives, statins, anticoagulants, antiarrhythmics and heart-failure lines.
Oncology
Cytotoxics, targeted therapy and supportive care — bortezomib, docetaxel, paclitaxel, gemcitabine.
Diabetes & endocrine
Insulins, oral antidiabetics, thyroid and hormonal therapy — 470+ lines across the spectrum.
CNS & neurology
Antiepileptics, antipsychotics, antidepressants, anxiolytics and neuroprotective lines.
General & OTC
Analgesics, vitamins, wound-care, nutritionals — 1,283 SKUs, our broadest catalogue.
Molecule, volume, target distributor. One working day to a quote.
Your enquiry goes directly to the account manager responsible for Oman. No call-centre hops, no generic autoresponders, just the answer your procurement file needs.
Start an Oman enquiry → Back to all markets